Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms

• Published in: Hypertension (Dallas, Tex. 1979) Vol. 49; no. 3; pp. 535 - 541
• Main Authors: Grassi, Guido, Seravalle, Gino, Quarti-Trevano, Fosca, Scopelliti, Francesco, DellʼOro, Raffaella, Bolla, Gianbattista, Mancia, Giuseppe
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Heart Association, Inc 01.03.2007; Hagerstown, MD Lippincott
• Subjects: Aged; Autonomic Nervous System Diseases - etiology; Autonomic Nervous System Diseases - physiopathology; Baroreflex; Biological and medical sciences; Cardiotonic agents; Cardiovascular system; Female; Heart Failure - complications; Heart Failure - physiopathology; Humans; Male; Medical sciences; Metabolic diseases; Metabolic Syndrome - complications; Metabolic Syndrome - physiopathology; Middle Aged; Obesity; Obesity - complications; Obesity - physiopathology; Pharmacology. Drug treatments; Sympathetic nerve; Potentiation; Cardiovascular disease; Body mass index; Heart disease; Electrocardiography; Complication; Arterial pressure; Blood pressure; Nutritional status; Human; Heart failure; Scanning electron microscopy; Obesity; Mortality; Nutrition disorder; Sympathetic nervous system; Left ventricle; Heart rate; metabolic syndrome; Baroreflex; Baroreceptor; Pressure measurement; Comparative study; Ejection fraction
• ISSN: 0194-911X; 1524-4563; 1524-4563
• DOI: 10.1161/01.HYP.0000255983.32896.b9

Congestive heart failure is characterized by sympathetic activation, which has also been described in the metabolic syndrome. No information exists, however, as to whether the sympathostimulating effects of these 2 conditions summate when heart failure is complicated by the metabolic syndrome, leading to an exceedingly high adrenergic drive. This is clinically relevant, because in heart failure sympathetic activation is closely related to mortality. We studied 48 control subjects (age58.4±1.6 years, mean±SEM) and 89 age-matched heart failure patients (New York Heart Association class II), of whom 47 were without and 42 were with metabolic syndrome. Measurements included blood pressure (Finapres), heart rate (ECG), and sympathetic nerve traffic (microneurography) at rest and during baroreceptor manipulation. Waist circumference, blood pressure, and metabolic variables were greater in heart failure with metabolic syndrome than in heart failure without metabolic syndrome and in control subjects. Left ventricular ejection fraction and end-diastolic diameter were similarly altered in the 2 heart failure groups. Compared with control subjects, sympathetic nerve activity was greater in heart failure patients without metabolic syndrome (64.7±3.2 versus 45.8±2.9 bursts/100 heartbeats; P<0.01), a further pronounced increase being detected in those with metabolic syndrome (80.9±3.2 bursts/100 heartbeats; P<0.01). In the multivariate analysis, waist circumference and body mass index were the variables most closely related to sympathetic activation. Compared with control subjects, baroreflex responses were significantly attenuated in the 2 heart failure groups, the impairment being more marked in the group with than without metabolic syndrome. Thus, obesity and metabolic syndrome potentiate the sympathetic activation characterizing heart failure. This potentiation is likely to mainly depend on metabolic and baroreflex mechanisms.